Association Between the Polymorphism of Angiotensin-Converting Enzyme Gene and Interleukin-1 Beta Gene and the Response to Erythropoietin Therapy in Dialysis Patients with Anemia.
P Dzekova-VidimliskiN Eftimovska-OtovikjI G NikolovGj SelimI Rambabova-BushljetikV PushevskiV KaranfilovskiN Matevska-GeshovskaA DimovskiPublished in: Balkan journal of medical genetics : BJMG (2024)
The polymorphism of the ACE and IL-1b genes was not significantly associated with the response to erythropoietin therapy in dialysis patients with anemia. Iron deficiency, malnutrition, and inflammation were factors associated with anemia and resistance to erythropoietin therapy in dialysis patients.
Keyphrases
- chronic kidney disease
- end stage renal disease
- iron deficiency
- angiotensin converting enzyme
- peritoneal dialysis
- angiotensin ii
- genome wide
- genome wide identification
- copy number
- newly diagnosed
- ejection fraction
- recombinant human
- gene expression
- dna methylation
- transcription factor
- cell therapy
- smoking cessation
- genome wide analysis